Tian Yongji, Liu Raynald, Qin Junji, Wang Junmei, Ma Zhenyu, Gong Jian, Li Chunde
Department of Neurosurgery, Beijing TianTan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases (NCRC-ND), Center for Brain Tumor, Beijing Institute for Brain Disorders, Beijing Key Laboratory for Brain Tumor, Beijing, China.
Department of Neuropathology, Beijing Neurosurgical Institute, Beijing, China.
World Neurosurg. 2018 Aug;116:e162-e168. doi: 10.1016/j.wneu.2018.04.135. Epub 2018 Apr 27.
Pineoblastoma is a rare malignant tumor of the pineal gland, which is more common in children.
We retrospectively reviewed 18 cases of pineoblastoma in children (10 girls), including general, clinical, and therapeutic information, and factors affecting prognosis.
The median age of the children was 51.7 months (range, 19-156 months). Presenting symptoms included vomiting (64.70%), headache (47.06%), weak or unsteady walking (35.29%), and nausea (29.41%). Rarer symptoms (1 patient each) included limb rigidity, inability to speak, double vision, fever, and Parinaud syndrome. Five and 13 children, respectively, underwent subtotal and gross total resection; 5 and 13 children received adjuvant craniospinal irradiation therapy and chemotherapy. Two children received both craniospinal irradiation and chemotherapy. The 5-year overall survival of the patients was 27.8% (5/18). The survival rate of children older than 4 years (66.7%) was significantly higher than that of younger children (8.3%). The 5-year overall survival rate of boys (50.7%) was higher than that of girls (10.0%); that of children who underwent gross total resection (30.8%) was higher than that of children who underwent subtotal resection (20.0%); and that of children treated with adjuvant craniospinal irradiation (50.7%) was higher than that of those not given craniospinal irradiation (10.0%). However, in each of these 3 comparisons the differences were not significant.
Pineoblastoma is rare but often fatal, especially in children younger than 4 years. Survival rates tend to be higher in boys, children undergoing gross total resection (rather than subtotal), and those given craniospinal irradiation.
松果体母细胞瘤是一种罕见的松果体恶性肿瘤,在儿童中更为常见。
我们回顾性分析了18例儿童松果体母细胞瘤病例(10例女孩),包括一般情况、临床及治疗信息,以及影响预后的因素。
患儿的中位年龄为51.7个月(范围19 - 156个月)。出现的症状包括呕吐(64.70%)、头痛(47.06%)、行走不稳或无力(35.29%)以及恶心(29.41%)。较罕见的症状(各1例)包括肢体僵硬、不能说话、复视、发热和帕里诺德综合征。分别有5例和13例儿童接受了次全切除和全切除;5例和13例儿童接受了辅助性全脑全脊髓放疗和化疗。2例儿童同时接受了全脑全脊髓放疗和化疗。患者的5年总生存率为27.8%(5/18)。4岁以上儿童的生存率(66.7%)显著高于年幼患儿(8.3%)。男孩的5年总生存率(50.7%)高于女孩(10.0%);接受全切除的儿童(30.8%)高于接受次全切除的儿童(20.0%);接受辅助性全脑全脊髓放疗的儿童(50.7%)高于未接受全脑全脊髓放疗的儿童(10.0%)。然而,在这3组比较中,差异均无统计学意义。
松果体母细胞瘤罕见但往往致命,尤其是在4岁以下儿童中。男孩、接受全切除(而非次全切除)的儿童以及接受全脑全脊髓放疗的儿童生存率往往较高。